Weight-loss drug for obese patients approved for use in Ireland 

Obesity affects more than 1m people in Ireland and is the major contributing factor to type 2 diabetes, affecting 200,000 people.

A weight-loss drug that helped obese people lose 15% body-weight in studies has been approved by the European Medicines Agency (EMA) and will be available in Ireland.

Obesity affects more than 1m people in Ireland and is the major contributing factor to type 2 diabetes, affecting 200,000 people.